Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Artrya Limited ( (AU:AYA) ) just unveiled an update.
Artrya Limited has announced the quotation of 200,000 ordinary fully paid securities on the Australian Securities Exchange (ASX) under the code AYA, effective from October 10, 2025. This move is part of the company’s strategy to enhance its market presence and potentially attract more investors, reflecting its ongoing commitment to growth and development in the healthcare sector.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on developing innovative solutions for the diagnosis and management of coronary artery disease. The company leverages advanced technology to provide healthcare professionals with tools to improve patient outcomes in cardiovascular health.
Average Trading Volume: 671,503
Technical Sentiment Signal: Buy
Current Market Cap: A$402.1M
For detailed information about AYA stock, go to TipRanks’ Stock Analysis page.